Clinical Application of a New Ternary Polymer, SEC-1 coat™, for Pediatric Cardiopulmonary Bypass Circuits: a Prospective Randomized Pilot Study
SEC-1 coat™ for cardiopulmonary bypass circuits have good biocompatibility with regard to platelet preservation and in terms of attenuating inflammatory reaction or coagulation activation during pediatric cardiac surgery.
Hyperlactatemia: An Update on Postoperative Lactate
In patients with evidence of adequate perfusion, a type B component is often associated with a concomitant balanced (normal anion gap) metabolic acidosis and hyperglycemia. These patients will benefit from a more nuanced approach to their type B hyperlactatemia, as many will have a benign course and may be managed expectantly.
Factors Associated With Survival Following Extracorporeal Cardiopulmonary Resuscitation in Children
Efforts to improve systemic output before and after institution of ECPR might mitigate some of the significant risk factors for mortality.
ECMO as a Platform for Rapid Ammonia Removal in a Neonate With Multienzyme Urea Cycle Disorder
This case will add to the existing scant literature supporting the use of ECMO as a platform for rapid removal of serum ammonia.
Deep Hypothermic Circulatory Arrest Activates Neural Precursor Cells in Neonatal Brain
Neonatal piglet ACP at 18°C or 25°C provides adequate protection from increased brain cellular apoptosis. In contrast to ACP however, DHCA induces brain Nestin expression, indicating activation of neural progenitor cells and the potential of altering neonatal neurodevelopmental progression.
Neck Cannulation for Bypass in Redo Sternotomy in Children and Adults with Congenital Heart Disease
Cannulation of the right neck vessels for peripheral cardiopulmonary bypass prior to high-risk redo sternotomy in children and adults with congenital heart disease is a safe and effective strategy.
COVID-19 FAQ’s in Pediatric Cardiac Surgery
The purpose of this review is to succinctly summarize frequently asked questions related to COVID-19 as it relates to children with congenital heart disease.
COVID-19: Crisis Management in Congenital Heart Surgery
The safety of our patients, healthcare providers, and our communities is our chief concern. This document is not meant to be a guideline but is designed to provide guidance for decision-making as we face unparalleled challenges related to congenital cardiac surgery care during this pandemic.
Are Blood Products Routinely Required in Pediatric Heart Surgery?
The majority of children with a BW > 8.5 kg required no blood products and those with a BW ≤ 8.5 kg required only 1 unit of blood, to prime the cardiopulmonary bypass circuit.
The Utility of Albumin Level as a Marker of Postoperative Course in Infants Undergoing Repair of Congenital Heart Disease
In summary, we found that preoperative and POD#2 albumin levels predicted prolonged and complicated postoperative course.
Cell-Cycle Arrest Biomarkers Usefulness for Cardiac Surgery-Related Acute Kidney Injury in Neonates and Infants
These findings question the usefulness of (TIMP-1) × (IGFBP-7) for the prediction of cardiac surgery-related acute kidney injury in neonates and infants when measured within 3 hours of cardiopulmonary bypass.
Frequency and Outcomes of Elevated Perioperative Lactate Levels in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery
Currently there is insufficient evidence to use lactate levels as a predictor of outcomes in adult patients with congenital heart disease undergoing cardiac surgery.